Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,667
Stocks News & Analysis
stocks
What does big US court decision mean for Google’s parent company Alphabet?
stocks
Is this still an ASX share to own forever?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,140.50 | 11.00 | 0.12% |
CAC 40 | 7,674.78 | 24.14 | -0.31% |
DAX 40 | 23,596.98 | 173.35 | -0.73% |
Dow JONES (US) | 45,400.86 | 220.43 | -0.48% |
FTSE 100 | 9,208.21 | 8.66 | -0.09% |
HKSE | 25,417.98 | 359.47 | 1.43% |
NASDAQ | 21,700.39 | 7.30 | -0.03% |
Nikkei 225 | 43,018.75 | 438.48 | 1.03% |
NZX 50 Index | 13,223.53 | 90.33 | 0.69% |
S&P 500 | 6,481.50 | 20.58 | -0.32% |
S&P/ASX 200 | 8,871.20 | 8.60 | 0.10% |
SSE Composite Index | 3,812.51 | 46.64 | 1.24% |